|
Market Closed -
Nasdaq
16:00:00 2026-08-18 EDT
|
5-day change | 1st Jan Change | ||
| 4.090 USD | +0.74% |
|
+4.34% | +154.04% |
| 08-17 | B. Riley Raises Price Target on MacroGenics to $11 From $9, Keeps Buy Rating | MT |
| 08-13 | MacroGenics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 7.25 | +78.57% | 4 | ||||||
| 182.53 | +9.37% | 18 | ||||||
| 1,036.98 | +4.68% | 14 | ||||||
| 200.05 | +55.9% | 22 | ||||||
| 40.85 | +2.95% | 23 | ||||||
| 104.26 | +31.58% | 20 | ||||||
| 1,312.17 | -6.94% | 8 | ||||||
| 2,410.59 | +14.57% | 15 | ||||||
| 573.12 | +9.69% | 18 | ||||||
| 52.94 | +1.18% | 16 | ||||||
| 110.18 | +24.22% | 11 | ||||||
| 678.06 | +29.19% | 16 | ||||||
| 144.2 | +85.34% | 21 | ||||||
| 20.99 | +122.66% | 13 | ||||||
| 109.9 | +44.85% | 20 | ||||||
| 124.71 | +19.23% | 14 | ||||||
| 99.56 | +43.17% | 16 | ||||||
| 85.5 | +0.88% | 10 | ||||||
| 109 | +81% | 9 | ||||||
| - | - | - | - | - | ||||
| Average | 389.62 | +34.32% | 15 | ||||||
| Weighted average by Cap. | 496.96 | +22.40% | 16 |
- Stock Market
- Stocks
- MGNX Stock
- Sector MacroGenics, Inc.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
